🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, multi-center, single arm study assessing the efficac...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2021-01-21
Trial ID
NCT04982549
Treatments Being Tested
Retinoblastoma is a childhood cancer which affects the retina of the eye. T...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2005-04-07
Trial ID
NCT00186888
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Unknown
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00417053
Treatments Being Tested
This is a randomized, open-label, prospective, multicenter phase III superi...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center,
Start Date
2026-08-11
Trial ID
NCT07678229
Ph-like ALL is a recently recognized high-risk subgroup and the optimal the...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital
Start Date
2016-02-14
Trial ID
NCT03564470
Based on the pediatric-inspired, PEG-L-asparaginase-intensified and MRD-dir...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital
Start Date
2016-02-14
Trial ID
NCT03564704
Treatments Being Tested
About 60% of patients with DLBCL can be cured with a chemotherapy program. ...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2008-07-01
Trial ID
NCT00712582
RATIONALE: Everolimus may stop the growth of tumor cells by blocking some o...
Status
Terminated
Location
University of California Davis Cancer Center
Start Date
2009-03
Trial ID
NCT00807755
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Haematologisch Onkologische Praxis
Start Date
2002-04
Trial ID
NCT00053768
Durvalumab and Tremelimumab in combination with first-line chemotherapy in ...
Status
Completed
Location
Research Site
Start Date
2016-04-28
Trial ID
NCT02658214
Treatments Being Tested